<DOC>
	<DOCNO>NCT00501878</DOCNO>
	<brief_summary>To compare clinical efficacy systemic side effect 2.5 % 10 % phenylephrine mydriasis diabetic patient darkly pigment iris .</brief_summary>
	<brief_title>2.5 % 10 % Phenylephrine Mydriasis Diabetic Patients With Darkly Pigmented Irides</brief_title>
	<detailed_description>One hundred patient diabetes Srinagarind Hospital Eye Clinic enrol randomize two group block randomization . In group I ( 50 patient ) , 1 % tropicamide combine 2.5 % phenylephrine administer dilate pupil whereas 1 % tropicamide combine 10 % phenylephrine use Group II ( 50 patient ) . Pupil diameter , blood pressure heart rate measure eye drop instillation .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Mydriasis</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<criteria>diabetic patient history intraocular surgery laser treatment , ocular disease might affect pupil size glaucoma , uveitis , Horner 's syndrome , Adies ' pupil , history allergy drug use , hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>phenylephrine</keyword>
	<keyword>mydriasis</keyword>
	<keyword>diabetes mellitus</keyword>
</DOC>